This work had two purposes: (i) to determine in vivo whether liver phenylalanine hydroxylase (PAH) is regulated by its substrates phenylalanine and tetrahydrobiopterin (BH4) as studies with purified enzyme suggest and (ii) to investigate in vivo the relationship between PAH activity and BH4 turnover. We found there are two BH4 pools in hepatocytes, one that is metabolically available (free BH4) and one that is not (bound BH4 Phenylalanine hydroxylase (PAH) catalyzes the hydroxylation of phenylalanine to tyrosine. This is the first step in phenylalanine degradation (1), and a block in the reaction causes phenylketonuria. Because the hydroxylation is irreversible and extracted liver PAH activity is very high in most animals (2), the enzyme is carefully regulated. In confirmation of this, purified PAH is kinetically complex (3-6). Its major regulators are phenylalanine and the reaction cofactor tetrahydrobiopterin (BH4) (Scheme I). Phenylalanine is a positive allosteric effector (activator) that converts inactive enzyme, Ei, to catalytically competent (activated) enzyme, Ea (7-9); BH4 is a negative effector that competes with phenylalanine activation to form a dead-end Ei(BH4) complex (3, 6, 7 BH4 has a central role in the regulatory scheme. The only other known BH4-requiring enzymes in liver, alkylglycerol monooxygenase (13) and nitric oxide synthase (14), have relatively low activities and are present in relatively low amounts; the major quantitative use of BH4 in liver appears to be in phenylalanine hydroxylation. Of importance here, the BH4 and PAH (subunit) concentrations in liver are approximately equal, being 8.5 ± 2 and 8-9 ,uM, respectively (10, 15).
found there are two BH4 pools in hepatocytes, one that is metabolically available (free BH4) and one that is not (bound BH4). Bound BH4 appears bound to PAH; the PAH-BH4 complex has much less catalytic activity and is less readily phenylalanine activated than uncomplexed enzyme. Interconversion of activated and unactivated PAH and bound and free B14 is driven by phenylalanine; and free BH4 concentration is determined by the state of activation and activity of PAH. In hepatocytes, BK1 and PAH (subunit) concentrations are equal, all intracellular BH4 appears to be available to PAH, and free BH4 turns over rapidly (til -1 hr). There is no evidence for feedback inhibition of BH4 synthesis; the BH4 synthetic rate appears high when free BH4 concentration is high and low when free BH4 is low. The data provide support in vivo that phenylalanine and BH4 are positive and negative regulators of the activity and activation state of PAH in the proposed manner, they also imply that regulation of BH4 turnover and PAH activity are linked processes, which are both controlled by phenylalanine concentration.
Phenylalanine hydroxylase (PAH) catalyzes the hydroxylation of phenylalanine to tyrosine. This is the first step in phenylalanine degradation (1) , and a block in the reaction causes phenylketonuria. Because the hydroxylation is irreversible and extracted liver PAH activity is very high in most animals (2), the enzyme is carefully regulated. In confirmation of this, purified PAH is kinetically complex (3) (4) (5) (6) . Its major regulators are phenylalanine and the reaction cofactor tetrahydrobiopterin (BH4) (Scheme I). Phenylalanine is a positive allosteric effector (activator) that converts inactive enzyme, Ei, to catalytically competent (activated) enzyme, Ea (7) (8) (9) ; BH4 is a negative effector that competes with phenylalanine activation to form a dead-end Ei(BH4) complex (3, 6, 7) .t The 4a-hydroxytetrahydrobiopterin [(4aOH)-BH4] is the initial pterin reaction product (12) and quinonoid dihydrobiopterin (qBH2) is its dehydration product. Dihydropterin reductase (DHPR) catalyzes reduction of qBH2 to BH4 (1, 3) and is an integral part of the hydroxylation system in vivo.
BH4 has a central role in the regulatory scheme. The only other known BH4-requiring enzymes in liver, alkylglycerol monooxygenase (13) and nitric oxide synthase (14) , have relatively low activities and are present in relatively low amounts; the major quantitative use of BH4 in liver appears to be in phenylalanine hydroxylation. Of importance here, the BH4 and PAH (subunit) concentrations in liver are approximately equal, being 8.5 ± 2 and 8-9 ,uM, respectively (10, 15) .
As a result, formation of Ei(BH4) will cause equal decreases in free enzyme and free BH4 concentrations, and phenylalanine, by controlling the Ei to Ea equilibrium, will control both the metabolic availability of BH4 and the amount of active PAH in a cell. Calculations using Scheme I and the BH4/enzyme equality predict that at physiologically relevant phenylalanine concentrations, BH4 will be a major inhibitor of PAH, and PAH and phenylalanine will be major determinants of intracellular free BH4 concentration (6 (10) with identical 50-kDa subunits (1).
There is one phenylalanine activation site per Ei subunit (5, 9, 11) , and activation to form Ea is cooperative (3, 7) . The binding of phenylalanine to Ei(BH4) to form inactive Ei(BH4,Phe) (6) is omitted from Scheme I, since the Kd for the interaction is very large (-4 mM), far outside the normal physiological range.
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per collagen-coated 60-mm dish) and maintained (37°C; 5% C02/95% air atmosphere) in standard medium (4 ml per dish). Medium was changed 4 hr after seeding and every 24 hr thereafter. Standard medium is as described (20) (15, 23) and quantitated by HPLC with fluorescence detection (365-nm excitation; 418-nm emission cutoff) on a 5-,um C18 column (0.46 x 25 cm) (Rainin) eluted at 1 ml/min with 5% methanol (aqueous). For extracellular biopterin, 25 ,tM NADP+, 2.5 ,ug of superoxide dismutase and catalase per ml, 91 ,ug of glucose 6-phosphate per ml, 10 ,tg of glucose-6-phosphate dehydrogenase per ml, and 7.3 Ag of DHPR per ml were added to the medium.
Quantitation was as described above except a 10-,um Partisil SCX column (Whatman) was used with 10% methanol in 0.1 AM sodium acetate (pH 4.0) as eluant (1.5 ml/min).
Intracellular Water Space. Hepatocytes on 15-mm collagencoated glass (Corning) coverslips were placed in standard medium containing 3H20 and 4.5 mM [14C]sucrose. After 30 min (37°C), coverslips were removed, rapidly drained, rinsed by agitation at 0°C in calcium, magnesium-free phosphatebuffered saline for times from 0.5 to 2 s, and placed into scintillation mixture (24) , and 3H and 14C cpm were determined. For each rinse time, intracellular 3H20 = total 3H -extracellular 3H (calculated from extracellular 14C and the medium 3H/14C ratio). Extracellular 14C = total 14C -adsorbed 14C -cell-associated 14C. These last two were determined at each time point, respectively, from 14C adsorption to coverslips without cells and from 14C that washed off cells extremely slowly. Extrapolation to zero time of a plot of ln(,ll of intracellular 3H20 per mg of protein) vs. rinsing time gave intracellular specific volume. Curves had 7 or 8 points and were determined in duplicate. Protein and DNA were determined on parallel coverslips. Dissociation Rate Constant (k0ff) of Ei(BH4). BH4 was added to a solution containing reduced PAH (25) , and the rate of Ei(BH4) formation was measured from fluorescence loss at 340 nm (293-nm excitation) (5) using an SLM 8000 spectrofluorometer. The reaction mixture (1.7 ml) contained 0.05 M potassium phosphate (pH 6.8), 0.1 M potassium chloride, 6 (Table 2) . Nearly all biopterin is in the form of BH4 in the cells. § Although phenylalanine concentration strongly affects the phenylalanine hydroxylation rate and, hence, BH4 use in hepatocytes, its effect on intracellular BH4 concentration is small and is not measurable on total biopterin (Fig. 1). [Unless indicated otherwise, data in a table or graph are from cultures harvested the same day: day 3, 4, or 5 of culture. When the cultures harvested on these days are compared, they show small (5-25%), approximately parallel increases in time of biopterin content, cell volumes (Table  3) , and PAH activity.]
Phenylalanine and BH4 Turnover. 2,4-Diamino-6-hydroxypyrimidine (DAP) inhibits GTP cyclohydrolase I, the first enzyme in the BH4 biosynthetic pathway (23, 27, 28) . Addition of 800 ,uM DAP to hepatocyte cultures causes a rapid biopterin loss ( Fig. 2) with a tyl2 of 1 hr, similar to til2 values of 2-5 hr for BH4 loss in other cell types (23, 27, 28) . The loss is assumed to be due to normal BH4 turnover, since DAP at 1 mM does not appear to be cytotoxic, and DAP removal allows complete §Intracellular BH4 and qBH2 cannot be separately quantitated by the present or any other method we know of; hence, intracellular BH4 is the sum of the BH4 and qBH2. In any event, little qBH2 is expected to be present, since DHPR appears to be in excess and qBH2 reduction to BH4 does not appear to be rate limiting. In fact, this last assumption is not correct. In Fig. 2 , much less BH4 is lost at 54 ,uM, a normal physiological concentration, than at 540 ,uM phenylalanine. Within experimental error, which is fairly large at 54 ,M, the k, values for formation of the new BH4 steady state are the same at 54 and 540 ,LM phenylalanine, being 0.54 ± 0.21 and 0.72 ± 0.06 hr-, respectively. Hence, the differences in final BH4 levels are due either to ko being -10x larger at 54 ,tM phenylalanine, which subsequent experiments exclude, or to there being two intra- Bound and Free BH4. From earlier work (5, 6) and Scheme I, the intracellular pools defined in Fig. 2 Fig. 3A shows that free and bound BH4 exist in hepatocytes and that their ratio depends on the phenylalanine concentration. The link between the bound/free BH4 ratio and phenylalanine concentration is almost certainly PAH, because phenylalanine-induced increases in free BH4 (Fig. 3A) are paralleled by increases in activated PAH (Fig. 3B ). This result indicates that bound BH4 retained by the filter cannot be BH4 or (4aOH)-BH4 at the active site of PAH, because both would be expected to increase with increasing phenylalanine, opposite what is found. The implication is that bound BH4 is an Ei(BH4) complex, consistent with Scheme I. Free BH4, therefore, must include unbound BH4, BH4 that was at the PAH active site, BH4 complexed with other molecules, qBH2, and (4aOH)-BH4, although, normally, little of the last two is expected to be present. Free and bound BH4 and relationship to PAH activation. (A) Hepatocyte cultures were shifted from standard medium (540 ,uM phenylalanine) to media with the indicated phenylalanine concentrations; 2 hr later cultures were harvested and analyzed for free and total intracellular biopterin. (B) Cultures were incubated in standard medium with (0) or without (0) 800 ,uM DAP. After 13 hr, the phenylalanine concentration in media was changed to the indicated values; 2 hr later, cultures were extracted and percentage of PAH that was activated, intracellular biopterin content, and culture protein were measured. Cultures with DAP had -10% as much biopterin as cultures without DAP. (C) DAP (800 ,uM) was added to hepatocyte cultures in standard medium. At each time point, four cultures were extracted: two for determination of total biopterin (pmol per mg of protein) (LI) and two for determination of percentage of PAH that was activated (-).
To some extent, the time of harvest affects free biopterin concentration. In cultures harvested 0.5, 2, and 12 hr after decreasing phenylalanine from 540 to 54 ,uM, free biopterin was 31% ± 3%, 19% ± 6%, and 11% ± 3% of total biopterin, respectively. Harvest times were usually 0.5 or 2 hr after changing medium; no correction is made for the time of harvest. Likewise, no correction is made for 7,8-BH2, which was always -10% of total cell biopterin. Both 7,8-BH2 and short harvest times cause slight (-15%) underestimates of bound BH4 at low phenylalanine concentrations. This has no effect on our conclusions.
Metabolic Availability of Free BH4. Several results indicate that increases in free B14 imply increases in thermodynamic activity of intracellular BH4. Thus, biopterin is transported to the medium more rapidly at high than at low phenylalanine concentration ( Table 4 ). The initial rate of BH4 loss after addition of DAP is -4 times faster at 540 ,uM than at 54 ,uM phenylalanine: 29 and 7.6 pmol of BH4 lost per min per mg of protein, respectively (Fig. 2) . Finally, the phenylalanine hydroxylation rate in situ increases =150-fold between 54 ,uM and 900 ,tM phenylalanine (Fig. 1) . Increases in phenylalanine and Ea concentrations can account for only a 50-fold increase in the hydroxylation rate: 12-fold from increases in Ea concentration and, assuming similar intra-and extracellular concentrations, 4-fold from increases in phenylalanine concentration (Km = 180 ,uM). But, by including the 5-fold increase in free BH4 implied in Fig. 3A , the total rate increase in Fig.  1 is accounted for.
Experiments with deaza-6MPH4 provide independent evidence for the nature of free and bound BH4. Deaza-6MPH4 is a competitive inhibitor in the PAH reaction (16) and, important here, it is also a competitive inhibitor of BH4 binding at the pterin regulatory site on Ei (5) . Addition of deaza-6MPH4 to cultures in 54 ,uM phenylalanine increases the free BH4 concentration (Table 5) , and, if DAP is present, deaza-6MPH4 triples the rate of BH4 loss from the cells (Table 5 (Fig. 3B) , and PAH activation is concurrent with BH4 loss (Fig. 3C ). Controls showed that DAP itself neither induces enzyme activation in situ nor affects extracted enzyme activity. Specifically, addition of 800 ,uM DAP to replicate cultures in standard medium containing 54 ,uM phenylalanine for 3 hr caused a slight decrease (5-10%) in total biopterin in the cells (as in Fig. 2 ) but had no effect on 
DISCUSSION
The present work shows that there are at least two quantitatively significant BH4 pools in hepatocytes: one that is metabolically available (free BR4) and one that is not (bound BH4). Bound BH4 appears to be bound to PAH, with the enzyme-BH4 complex having much less catalytic activity and being less readily phenylalanine-activated than uncomplexed enzyme, and with the bound/free BH4 ratio and the activated/ unactivated enzyme ratio (Ea/Ei) being determined by phenylalanine concentration. Together, the experiments provide support in situ for the proposal that PAH is regulated as shown in Scheme I; they imply, in addition, that regulation of BH4 turnover and PAH activity are linked processes, both controlled by phenylalanine concentration.
Originally, regulation of BH4 synthesis was ascribed to direct feedback inhibition by BH4 of GTP cyclohydrolase I (27) . Recently (29) , however, it was reported that the effect of BH4 on BH4 synthesis was indirect, being mediated by p35, a protein in a 30-to 40-kDa fraction of rat liver extract. Through p35, BH4 was said to be a feedback inhibitor and phenylalanine an activator of GTP cyclohydrolase I (29) . The present studies, which examine BH4 disposition in situ, are difficult to reconcile with either direct or indirect feedback inhibition by BH4 as the mechanism of regulation, because the apparent rate of BH4 synthesis is high when free BH4 concentration is high and low when free BH4 is low. There are, however, striking similarities in effects of BH4 and phenylalanine on p35 action (29) and on PAH activity, suggesting that one or more forms of PAH might be effectors of p35 or of GTP cyclohydrolase I itself. Thus, in Scheme I, if the Ei(BH4) complex is a negative effector and Ea is a positive effector of BH4 synthesis, one would satisfy many of the regulatory requirements and directly connect PAH activity and BH4 turnover. Whether a form of PAH is a direct effector or there is an intermediate protein between PAH and GTP cyclohydrolase I, regulation of PAH activity and of BH4 turnover and availability appear to be interconnected. In hepatocytes, the rate of BH4 synthesis reflects the state of activation and activity of PAH, and the amount of BH4 is constant and equal to the PAH concentration independent of changes in the rate of BH4 synthesis, the amount of BH4 bound to PAH, or the concentration of phenylalanine (Fig. 1) .
Although not studied in the same detail, liver PAH in other animals appears to have regulatory properties similar to rat PAH (9), indicating that Scheme I might apply to BH4 and PAH regulation in other species. Consistent with this, in human plasma BH4 concentration is high if either liver PAH is inactive or plasma phenylalanine is high (30) , exactly as expected from the data given here and from Scheme I. The present results could also apply to BH4 regulation in nonliver cells. Thus, it seems possible that BH4 turnover and the activity and amount of tryptophan and tyrosine hydroxylases in serotonin-and catecholamine-producing cells could be regulated in a manner analogous to that of BH4 and PAH in hepatocytes.
